Amwill Health Care Limited (BOM:544353)
India · Delayed Price · Currency is INR 44.00
+2.36 (5.67%)
At close: Nov 6, 2026
Amwill Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 469.16 | 454.92 | 405.82 | 439.48 | 301.66 | 276.13 | |
Revenue Growth | 21.45% | 12.10% | -7.66% | 45.69% | 9.25% | 53.41% |
Cost of Revenue | 148.48 | 136.83 | 116.16 | 121.1 | 90.68 | 87.71 |
Gross Profit | 320.68 | 318.1 | 289.66 | 318.38 | 210.98 | 188.43 |
Selling, General & Admin | 123.52 | 120.92 | 102.41 | 94.22 | 104.82 | 86.93 |
Other Operating Expenses | 73.39 | 66.77 | 70.21 | 57.49 | 62.74 | 64.02 |
Operating Expenses | 202.4 | 193.14 | 177.7 | 154.1 | 170.4 | 154.22 |
Operating Income | 118.28 | 124.96 | 111.96 | 164.28 | 40.58 | 34.2 |
Interest & Investment Income | 28.82 | 28.82 | 7.07 | 3.08 | 1.16 | 0.02 |
Other Non Operating Income (Expenses) | 5.89 | - | - | - | - | - |
EBT Excluding Unusual Items | 152.99 | 153.77 | 119.03 | 167.36 | 41.74 | 34.22 |
Gain (Loss) on Sale of Investments | 0.37 | 0.37 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.49 | -0.49 | - | 0.28 | - | -0.88 |
Pretax Income | 152.88 | 153.66 | 119.03 | 167.64 | 41.74 | 33.35 |
Income Tax Expense | 40.67 | 39.45 | 11.73 | 42.64 | 10.6 | 7.61 |
Net Income | 112.21 | 114.21 | 107.3 | 125 | 31.14 | 25.74 |
Net Income to Common | 112.21 | 114.21 | 107.3 | 125 | 31.14 | 25.74 |
Net Income Growth | 38.75% | 6.44% | -14.16% | 301.36% | 21.01% | - |
Shares Outstanding (Basic) | 25 | 20 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 25 | 20 | 16 | 16 | 16 | 16 |
Shares Change | 35.28% | 23.64% | 3.71% | 0.02% | - | - |
EPS (Basic) | 4.52 | 5.71 | 6.63 | 8.01 | 2.00 | 1.65 |
EPS (Diluted) | 4.52 | 5.71 | 6.63 | 8.01 | 2.00 | 1.65 |
EPS Growth | 2.56% | -13.91% | -17.23% | 301.27% | 21.02% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 76.92 | 74.18 | 48.48 | -39.47 | 44.77 | 29.07 |
Free Cash Flow Per Share | 3.10 | 3.71 | 3.00 | -2.53 | 2.87 | 1.86 |
Dividend Per Share | - | 0.500 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 68.35% | 69.92% | 71.38% | 72.45% | 69.94% | 68.24% |
Operating Margin | 25.21% | 27.47% | 27.59% | 37.38% | 13.45% | 12.39% |
Profit Margin | 23.92% | 25.11% | 26.44% | 28.44% | 10.32% | 9.32% |
Free Cash Flow Margin | 16.39% | 16.31% | 11.95% | -8.98% | 14.84% | 10.53% |
EBITDA | 123.65 | 130.29 | 116.32 | 166.62 | 42.89 | 37.46 |
EBITDA Margin | 26.36% | 28.64% | 28.66% | 37.91% | 14.22% | 13.56% |
D&A For EBITDA | 5.37 | 5.34 | 4.36 | 2.33 | 2.31 | 3.25 |
EBIT | 118.28 | 124.96 | 111.96 | 164.28 | 40.58 | 34.2 |
EBIT Margin | 25.21% | 27.47% | 27.59% | 37.38% | 13.45% | 12.39% |
Effective Tax Rate | 26.60% | 25.67% | 9.86% | 25.44% | 25.39% | 22.82% |
Revenue as Reported | 504.24 | 484.11 | 412.89 | 442.84 | 302.83 | 276.15 |
Advertising Expenses | - | 33.37 | 27.26 | 37.68 | 29.33 | 22.34 |